Filgotinib for treating moderate to severe rheumatoid arthritis

Equality Impact Assessment (Guidance development) (PDF 154 KB)

Final draft guidance

Final appraisal document (PDF 357 KB)

Committee papers (PDF 10.63 MB)

Public committee slides (PDF 1.25 MB)

Final stakeholder list (PDF 188 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 323 KB)

Final scope (PDF 214 KB)

Equality impact assessment (Scoping) (PDF 118 KB)

Draft scope pre referral (PDF 231 KB)

Draft matrix pre referral (PDF 188 KB)